164 related articles for article (PubMed ID: 36716775)
1. Decreased Platelet Reactivity and Function in a Mouse Model of Human Pancreatic Cancer.
Kawano T; Hisada Y; Grover SP; Schug WJ; Paul DS; Bergmeier W; Mackman N
Thromb Haemost; 2023 May; 123(5):501-509. PubMed ID: 36716775
[TBL] [Abstract][Full Text] [Related]
2. Tissue factor-positive tumor microvesicles activate platelets and enhance thrombosis in mice.
Geddings JE; Hisada Y; Boulaftali Y; Getz TM; Whelihan M; Fuentes R; Dee R; Cooley BC; Key NS; Wolberg AS; Bergmeier W; Mackman N
J Thromb Haemost; 2016 Jan; 14(1):153-66. PubMed ID: 26516108
[TBL] [Abstract][Full Text] [Related]
3. Human pancreatic tumors grown in mice release tissue factor-positive microvesicles that increase venous clot size.
Hisada Y; Ay C; Auriemma AC; Cooley BC; Mackman N
J Thromb Haemost; 2017 Nov; 15(11):2208-2217. PubMed ID: 28834179
[TBL] [Abstract][Full Text] [Related]
4. An α
Kuo YJ; Chen YR; Hsu CC; Peng HC; Huang TF
J Thromb Haemost; 2017 Nov; 15(11):2230-2244. PubMed ID: 28815933
[TBL] [Abstract][Full Text] [Related]
5. Ca
Tamang HK; Yang RB; Song ZH; Hsu SC; Peng CC; Tung YC; Tzeng BH; Chen CC
J Thromb Haemost; 2022 Aug; 20(8):1887-1899. PubMed ID: 35490411
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of platelet activation prevents the P-selectin and integrin-dependent accumulation of cancer cell microparticles and reduces tumor growth and metastasis in vivo.
Mezouar S; Darbousset R; Dignat-George F; Panicot-Dubois L; Dubois C
Int J Cancer; 2015 Jan; 136(2):462-75. PubMed ID: 24889539
[TBL] [Abstract][Full Text] [Related]
7. Reelin Amplifies Glycoprotein VI Activation and AlphaIIb Beta3 Integrin Outside-In Signaling via PLC Gamma 2 and Rho GTPases.
Krueger I; Gremer L; Mangels L; Klier M; Jurk K; Willbold D; Bock HH; Elvers M
Arterioscler Thromb Vasc Biol; 2020 Oct; 40(10):2391-2403. PubMed ID: 32787521
[TBL] [Abstract][Full Text] [Related]
8. NLRP3 regulates platelet integrin αIIbβ3 outside-in signaling, hemostasis and arterial thrombosis.
Qiao J; Wu X; Luo Q; Wei G; Xu M; Wu Y; Liu Y; Li X; Zi J; Ju W; Fu L; Chen C; Wu Q; Zhu S; Qi K; Li D; Li Z; Andrews RK; Zeng L; Gardiner EE; Xu K
Haematologica; 2018 Sep; 103(9):1568-1576. PubMed ID: 29794149
[TBL] [Abstract][Full Text] [Related]
9. First description of an IgM monoclonal antibody causing α
Pillois X; Guy A; Choquet É; James C; Tuffigo M; Viallard JF; Garcia C; Bordet JC; Jandrot-Perrus M; Payrastre B; Fiore M
J Thromb Haemost; 2019 May; 17(5):795-802. PubMed ID: 30868743
[TBL] [Abstract][Full Text] [Related]
10. Norcantharidin, a clinical used chemotherapeutic agent, acts as a powerful inhibitor by interfering with fibrinogen-integrin α
Hsia CH; Lu WJ; Lin KH; Chou DS; Geraldine P; Jayakuma T; Chang NC; Sheu JR
J Cell Mol Med; 2018 Apr; 22(4):2142-2152. PubMed ID: 29369482
[TBL] [Abstract][Full Text] [Related]
11. Functional Relevance of the Anaphylatoxin Receptor C3aR for Platelet Function and Arterial Thrombus Formation Marks an Intersection Point Between Innate Immunity and Thrombosis.
Sauter RJ; Sauter M; Reis ES; Emschermann FN; Nording H; Ebenhöch S; Kraft P; Münzer P; Mauler M; Rheinlaender J; Madlung J; Edlich F; Schäffer TE; Meuth SG; Duerschmied D; Geisler T; Borst O; Gawaz M; Kleinschnitz C; Lambris JD; Langer HF
Circulation; 2018 Oct; 138(16):1720-1735. PubMed ID: 29802205
[TBL] [Abstract][Full Text] [Related]
12. Activation and shedding of platelet glycoprotein IIb/IIIa under non-physiological shear stress.
Chen Z; Mondal NK; Ding J; Koenig SC; Slaughter MS; Griffith BP; Wu ZJ
Mol Cell Biochem; 2015 Nov; 409(1-2):93-101. PubMed ID: 26160282
[TBL] [Abstract][Full Text] [Related]
13. Antagonism of the GPIIb/IIIa receptor with the nonpeptidic molecule BIBU52: inhibition of platelet aggregation in vitro and antithrombotic efficacy in vivo.
Guth BD; Seewaldt-Becker E; Himmelsbach F; Weisenberger H; Müller TH
J Cardiovasc Pharmacol; 1997 Aug; 30(2):261-72. PubMed ID: 9269956
[TBL] [Abstract][Full Text] [Related]
14. Mice Expressing Low Levels of CalDAG-GEFI Exhibit Markedly Impaired Platelet Activation With Minor Impact on Hemostasis.
Piatt R; Paul DS; Lee RH; McKenzie SE; Parise LV; Cowley DO; Cooley BC; Bergmeier W
Arterioscler Thromb Vasc Biol; 2016 Sep; 36(9):1838-46. PubMed ID: 27417588
[TBL] [Abstract][Full Text] [Related]
15. The transmembrane protein disulfide isomerase TMX1 negatively regulates platelet responses.
Zhao Z; Wu Y; Zhou J; Chen F; Yang A; Essex DW
Blood; 2019 Jan; 133(3):246-251. PubMed ID: 30425049
[TBL] [Abstract][Full Text] [Related]
16. The disulfide isomerase ERp72 supports arterial thrombosis in mice.
Zhou J; Wu Y; Chen F; Wang L; Rauova L; Hayes VM; Poncz M; Li H; Liu T; Liu J; Essex DW
Blood; 2017 Aug; 130(6):817-828. PubMed ID: 28576878
[TBL] [Abstract][Full Text] [Related]
17. Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca
Morikawa Y; Kato H; Kashiwagi H; Nishiura N; Akuta K; Honda S; Kanakura Y; Tomiyama Y
Thromb Res; 2018 Feb; 162():44-52. PubMed ID: 29289806
[TBL] [Abstract][Full Text] [Related]
18. The β isoform of the catalytic subunit of protein phosphatase 2B restrains platelet function by suppressing outside-in αII b β3 integrin signaling.
Khatlani T; Pradhan S; Da Q; Gushiken FC; Bergeron AL; Langlois KW; Molkentin JD; Rumbaut RE; Vijayan KV
J Thromb Haemost; 2014 Dec; 12(12):2089-101. PubMed ID: 25330904
[TBL] [Abstract][Full Text] [Related]
19. Fatty acid oxidation fuels agonist-induced platelet activation and thrombus formation: Targeting β-oxidation of fatty acids as an effective anti-platelet strategy.
Kulkarni PP; Ekhlak M; Singh V; Kailashiya V; Singh N; Dash D
FASEB J; 2023 Feb; 37(2):e22768. PubMed ID: 36624703
[TBL] [Abstract][Full Text] [Related]
20. The Antithrombotic Agent Pterostilbene Interferes with Integrin α
Huang WC; Lin KC; Hsia CW; Hsia CH; Chen TY; Bhavan PS; Sheu JR; Hou SM
Int J Mol Sci; 2021 Mar; 22(7):. PubMed ID: 33807403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
